Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Christopher Jones

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 10, 2019
Fatal neutropenic enterocolitis associated with docetaxel use: A review of cases reported to the United States Food and Drug Administration Adverse Event Reporting SystemPritpal Singh, Afrouz Nayernama, S Christopher Jones, et al.
JAMA Oncology|August 18, 2022
Postmarketing Colitis Cases Associated With Alpelisib Use Reported to the US Food and Drug AdministrationKathleen M Sullivan, Graça M Dores, Afrouz Nayernama, et al.
Drug Safety|October 26, 2021
Repeated or Continuous Medically Supervised Ketamine Administration Associated with Hepatobiliary Adverse Events: A Retrospective Case SeriesSamantha Cotter, Jennie Wong, Neha Gada, et al.
International Urogynecology Journal|September 10, 2021
Pentosan associated retinal pigmentary changes: FDA's perspective on an emerging postmarketing safety findingAllison Lardieri, Karen Konkel, Lynda McCulley, et al.
Vascular Medicine (London, England)|April 12, 2021
Arterial aneurysm and dissection with systemic vascular endothelial growth factor inhibitors: A review of cases reported to the FDA Adverse Event Reporting System and published in the literatureConnie Cheng, Michelle Nadeau Nguyen, Afrouz Nayernama, et al.
The Annals of Pharmacotherapy|May 7, 2019
Discontinuation of Direct Oral Anticoagulants in Response to Attorney Advertisements: Data From the FDA Adverse Event Reporting SystemMohamed Mohamoud, Saharat Patanavanich, Page Crew, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 11, 2025
New Onset Pruritus Following Discontinuation of Cetirizine or LevocetirizineKaren Konkel, Jenni Yoon Lee, S Christopher Jones, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 13, 2018
Disseminated Gonococcal Infections in Patients Receiving Eculizumab: A Case SeriesPage E Crew, Winston E Abara, Lynda McCulley, et al.
Pharmacoepidemiology and Drug Safety|May 30, 2014
Use of an active surveillance system by the FDA to observe patterns of quinine sulfate use and adverse hematologic outcomes in CMS Medicare dataMonika Houstoun, Marsha E Reichman, David J Graham, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 12, 2012
Emergency use authorization for intravenous peramivir: evaluation of safety in the treatment of hospitalized patients infected with 2009 H1N1 influenza A virusAlfred Sorbello, S Christopher Jones, Wendy Carter, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 10, 2019
Fatal neutropenic enterocolitis associated with docetaxel use: A review of cases reported to the United States Food and Drug Administration Adverse Event Reporting SystemPritpal Singh, Afrouz Nayernama, S Christopher Jones, et al.
JAMA Oncology|August 18, 2022
Postmarketing Colitis Cases Associated With Alpelisib Use Reported to the US Food and Drug AdministrationKathleen M Sullivan, Graça M Dores, Afrouz Nayernama, et al.
Drug Safety|October 26, 2021
Repeated or Continuous Medically Supervised Ketamine Administration Associated with Hepatobiliary Adverse Events: A Retrospective Case SeriesSamantha Cotter, Jennie Wong, Neha Gada, et al.
International Urogynecology Journal|September 10, 2021
Pentosan associated retinal pigmentary changes: FDA's perspective on an emerging postmarketing safety findingAllison Lardieri, Karen Konkel, Lynda McCulley, et al.
Vascular Medicine (London, England)|April 12, 2021
Arterial aneurysm and dissection with systemic vascular endothelial growth factor inhibitors: A review of cases reported to the FDA Adverse Event Reporting System and published in the literatureConnie Cheng, Michelle Nadeau Nguyen, Afrouz Nayernama, et al.
The Annals of Pharmacotherapy|May 7, 2019
Discontinuation of Direct Oral Anticoagulants in Response to Attorney Advertisements: Data From the FDA Adverse Event Reporting SystemMohamed Mohamoud, Saharat Patanavanich, Page Crew, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 11, 2025
New Onset Pruritus Following Discontinuation of Cetirizine or LevocetirizineKaren Konkel, Jenni Yoon Lee, S Christopher Jones, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 13, 2018
Disseminated Gonococcal Infections in Patients Receiving Eculizumab: A Case SeriesPage E Crew, Winston E Abara, Lynda McCulley, et al.
Pharmacoepidemiology and Drug Safety|May 30, 2014
Use of an active surveillance system by the FDA to observe patterns of quinine sulfate use and adverse hematologic outcomes in CMS Medicare dataMonika Houstoun, Marsha E Reichman, David J Graham, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 12, 2012
Emergency use authorization for intravenous peramivir: evaluation of safety in the treatment of hospitalized patients infected with 2009 H1N1 influenza A virusAlfred Sorbello, S Christopher Jones, Wendy Carter, et al.
Pageof 4